Previous 10 | Next 10 |
Gainers: Viveve Medical (NASDAQ: VIVE ) +91% . Achillion Pharmaceuticals (NASDAQ: ACHN ) +71% . Regional Health Properties (NYSEMKT: RHE ) +53% . Xenetic Biosciences (NASDAQ: XBIO ) +44% . Assembly Biosciences (NASDAQ: ASMB ) +30% . Ideal Power (NASDAQ: IPWR ) +29% . Aethlon Me...
In response to the company's announcement of preliminary results for the third quarter of 2019, shares of ViewRay (NASDAQ: VRAY) , a medical equipment provider that has been beaten down recently , were up as much as 29% in early morning trading on Tuesday. The stock was up about 8%...
Westwater Resources (NASDAQ: WWR ) +130% on receiving first shipment of graphite concentrate. More news on: Westwater Resources, Inc., Reata Pharmaceuticals, Inc., NF Energy Saving Corporation, Stocks on the move, Read more ...
ViewRay (NASDAQ: VRAY ) is up 13% premarket on announcing preliminary Q3 2019 results: More news on: ViewRay, Inc., Healthcare stocks news, Stocks on the move, Read more ...
CLEVELAND , Oct. 15, 2019 /PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) today announced preliminary results for the third quarter 2019. The preliminary results have not been audited and are subject to change. Selected Third Quarter Preliminary Results: Total revenue of $20.9...
CLEVELAND , Oct. 7, 2019 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today that patient treatments are scheduled to begin in Boston with ViewRay's MRIdian® Linac System at Dana-Farber/Brigham and Women's Cancer Center. The MRIdian provides for the delivery of radiation t...
Class-action law firm urges VRAY investors who have suffered significant losses (in excess of $50,000) to learn their shareholder rights SAN FRANCISCO, CA / ACCESSWIRE / September 26, 2019 / Hagens Berman notifies VRAY investors of a securities fraud lawsuit filed against ViewRa...
New York, New York--(Newsfile Corp. - September 20, 2019) - Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in ViewRay, Inc. (NASDAQ: VRAY) ("ViewRay" or the "Company") of the November 12, 2019 deadline to seek the role of lead plaintiff in a federal s...
NEW YORK, Sept. 17, 2019 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in ViewRay, Inc. (“ViewRay” or the “Company”) (NASDAQ: VRAY) of the November 12, 2019 deadline to seek the role of lead plaintiff in a...
Glancy Prongay & Murray LLP (“GPM”) announces an investigation on behalf of ViewRay, Inc. (“ViewRay” or the “Company”) (NASDAQ: VRAY ) investors concerning the Company and its officers’ possible violations of federal securities laws. ...
News, Short Squeeze, Breakout and More Instantly...
ViewRay® Announces Commencement of Nasdaq Delisting Proceedings: Common Stock Expected to Begin Trading on the OTC Markets PR Newswire DENVER , July 21, 2023 /PRNewswire/ -- ViewRay, Inc. (the "Company") (Nasdaq: VRAY) announced today that on July 17 , i...